• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

    1.480 -0.030 (-1.99%)
    Streaming Delayed Price Updated: 11:33 AM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about SciSparc Ltd. - Ordinary Shares

    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    News headline image
    SciSparc Files Annual Report For Year Ended December 31, 2021 And Provides Corporate Update ↗
    TEL AVIV, Israel, May 2, 2022 /PRNewswire/ -- SciSparc Ltd. 
    Via Benzinga
    News headline image
    55 Biggest Movers From Friday ↗
    Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate... 
    Via Benzinga
    News headline image
    12 Stocks Halted On A Circuit Breaker This Week ↗
    A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and... 
    Via Benzinga
    News headline image
    50 Biggest Movers From Yesterday ↗
    Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
    Via Benzinga
    News headline image
    36 Stocks Moving In Friday's Mid-Day Session ↗
    Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... 
    Via Benzinga
    News headline image
    Mid-Morning Market Update: Markets Mixed; US Pending Home Sales Index Drop 4.1% ↗
    U.S. stocks traded opened on a mixed note this morning, with the Dow Jones gaining around 80 points on Friday. Following the market opening, the Dow traded up 0.25% to 34,795.46... 
    Via Benzinga
    News headline image
    Alcoholism & Psychedelics: Clearmind Trials Reveal Certain Psychedelics Help Reduce Alcohol Consumption In Mice ↗
    Clearmind Medicine Inc. 
    Via Benzinga
    News headline image
    Clearmind Medicine, SciSparc Launch A Psychedelic Pharma Collaboration ↗
    Psychedelic-focused biotech company Clearmind Medicine Inc. (CSE:CMND) (OTC: CMNDF) has signed a collaboration agreement with ... 
    Via Benzinga
    News headline image
    Meet a Company Harnessnessing the Power of Synergy for its Drug Therapeutics ↗
    Photo by Roberto Sorin on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.... 
    Via Benzinga
    SciSparc Has Been Granted The Patent in the United States for its Core Technology, Used to Treat Central Nervous System Disorders.
    Via AB Newswire
    Topics Intellectual Property
    News headline image
    68 Biggest Movers From Yesterday ↗
    Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
    Via Benzinga
    Advances for Tourette Syndrome, Alzheimer’s Disease, Pain Management, Autism Spectrum Disorder and Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC)
    Via Get News
    Advances for Tourette Syndrome, Alzheimer's Disease, Pain Management, Autism Spectrum Disorder and Epilepsy from Proprietary Compounds: SciSparc Ltd. (NASDAQ: SPRC) SPRC Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems
    Via Viz Release
    Topics Intellectual Property
    Pharmaceutical company SciSparc Ltd to make progress in treating nervous system disorders in 2022
    Via AB Newswire
    < Previous 1 2
    ...
    10 11 12 13 14 15 16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.